- The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
-
Parker DC, Cookson MS
- KMID: 2469121
- Investig Clin Urol.
- 2020 Feb;61(Suppl 1):S3-S7.
- doi: 10.4111/icu.2020.61.S1.S3
Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to... -
- CITED
-
- Close
- SHARE
-
- Close
